- Home
- ·
- About
About Professor Malcolm Finlay
Consultant Cardiologist at Barts Heart Centre since 2014, with honorary positions at UCL and QMUL. A specialist in cardiac electrophysiology and an expert in interventional arrhythmia management, including catheter ablation and cardiac implantable devices.
“I put my patients first, and care deeply that they have access to the best care and decisions available.”
Safe. Compassionate. Expert.
Professor Finlay qualified from Oxford University and completed his PhD at UCL, supported by a prestigious Wellcome Trust Research Fellowship — developing innovative, minimally invasive approaches to heart rhythm care.
Appointed Consultant Cardiologist at Barts Heart Centre in 2014 — Europe’s largest specialised cardiovascular centre — he is an expert in interventional arrhythmia management, including catheter ablation and cardiac implantable devices, and a UK pioneer of pulsed field ablation.
He pioneered day-case AF ablation performed in under an hour, with high success rates and low complication rates, and led a standardised waiting-list programme that cut complex ablation waits by around 50%. His clinical protocols were distributed nationally by HEE / NHS England.
His research has been published in leading journals including the European Heart Journal, Heart Rhythm and PLoS ONE.
Professor Finlay is also known for his innovation and entrepreneurial work — having founded three medical-technology companies, as well as Radnor Medical — and is published widely across the field of cardiology, routinely speaking at international conferences.
- BA (Oxon)
- BM BCh
- PhD (UCL)
- FRCP
- Consultant, Barts Heart Centre
4.99
“First class experience of a first class medical professional. Professor Finlay and his team made me feel safe, well cared for and relaxed during a pretty stressful time. Fabulous.”
INNOVATION & RESEARCH
At the frontier of heart rhythm technology
Echopoint Medical
Founder, Director & Chief Medical Officer — UCL spin-out that raised £2.8M+ developing coronary flow-sensing microcatheters, including the iKOr system.
Rhythm AI · STAR Mapping™
Founder — Barts Health spin-out developing revolutionary methods to target AF ablation more effectively; £2.3M raised, patents licensed.
Epicardio
Co-founder — the world’s first web-delivered whole-heart electrical simulation, licensed by Oxford, the Cleveland Clinic and Boston Scientific.
Optical Ultrasound
Patented technology developed with UCL Engineering — earning an honorary Senior Lectureship in Medical Physics & Bioengineering.
Welbeck London
Professor Finlay serves on the board of Welbeck Heart Health — the heart specialists’ group at Welbeck London, where he sees private patients.
Professional leadership
- EHRA Innovation Committee member
- Welbeck Heart Health — Board Member
- EHRA Scientific Initiatives Committee member
- EHRA Examination Standard Settings Committee
- Abstract Chair, Heart Rhythm Congress UK
- Faculty at national & international conferences
Clinical achievements
- Pioneered day-case AF ablation — under one hour, high success, low complications
- Cut complex ablation waiting times by ~50% with a standardised programme
- Clinical protocols distributed nationally by HEE / NHS England
- First mobile-phone phonocardiogram diagnosis (2006)
- First hybrid surgical device implantation technique (2015)
Licensed private pilot
Pianist, bass & double bass
Super-8 film premiered at Cannes (2008)
Father of two sons
CAREER MILESTONES
Two decades at the leading edge
2001
Qualified — Oxford University
BA (Oxon), BM BCh
2014
PhD & consultant post
Wellcome Trust PhD (UCL); appointed Consultant, Barts Heart Centre
2018
Founded Echopoint & Rhythm AI
UCL and Barts Health spin-outs
Today
UK pioneer of PFA
Day-case pulsed field ablation, teaching internationally
Take the first step towards peace of mind
Request an appointment and the PA will call you back — usually the same working day.